For: | Shiny TN, Mahajan VK, Mehta KS, Chauhan PS, Rawat R, Sharma R. Patch testing and cross sensitivity study of adverse cutaneous drug reactions due to anticonvulsants: A preliminary report. World J Methodol 2017; 7(1): 25-32 [PMID: 28396847 DOI: 10.5662/wjm.v7.i1.25] |
---|---|
URL: | https://www.wjgnet.com/2222-0682/full/v7/i1/25.htm |
Number | Citing Articles |
1 |
M. El Khoury, H. Assier, G. Gener, M. Paul, C. Haddad, O. Chosidow, P. Wolkenstein, S. Ingen-Housz-Oro. Polysensitivity in delayed cutaneous adverse drug reactions to macrolides, clindamycin and pristinamycin: clinical history and patch testing. British Journal of Dermatology 2018; 179(4): 978 doi: 10.1111/bjd.16738
|
2 |
Ilknur Kulhas Celik, Emine Dibek Misirlioglu, Can Naci Kocabas. Recent developments in drug hypersensitivity in children. Expert Review of Clinical Immunology 2019; 15(7): 723 doi: 10.1080/1744666X.2019.1612241
|
3 |
Annick Barbaud, Julie Castagna, Angèle Soria. Skin tests in the work‐up of cutaneous adverse drug reactions: A review and update. Contact Dermatitis 2022; 86(5): 344 doi: 10.1111/cod.14063
|
4 |
Aslı Gelincik, Ozlem Cavkaytar, Semanur Kuyucu. An Update on the Management of Severe Cutaneous Drug Hypersensitivity Reactions. Current Pharmaceutical Design 2019; 25(36): 3881 doi: 10.2174/1381612825666191106115556
|
5 |
Blake J. McKinley, J. Scott Parkinson. Stevens-Johnson syndrome linked to tramadol use and ultraviolet radiation. Medicine: Case Reports and Study Protocols 2021; 2(12): e0176 doi: 10.1097/MD9.0000000000000176
|
6 |
Lisanne E. N. Manson, Patricia C. Y. Chan, Stefan Böhringer, Henk-Jan Guchelaar. Genotyping for HLA risk alleles versus patch tests to diagnose anti-seizure medication induced cutaneous adverse drug reactions. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1061419
|
7 |
Marianne Lerch, Carlo Mainetti, Benedetta Terziroli Beretta-Piccoli, Thomas Harr. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Clinical Reviews in Allergy & Immunology 2018; 54(1): 147 doi: 10.1007/s12016-017-8654-z
|
8 |
Carina M. Woodruff, Nina Botto. The Role of Patch Testing in Evaluating Delayed Hypersensitivity Reactions to Medications. Clinical Reviews in Allergy & Immunology 2022; 62(3): 548 doi: 10.1007/s12016-022-08924-2
|
9 |
Marina Atanasković‐Marković, Jelena Janković, Vladimir Tmušić, Marija Gavrović‐Jankulović, Tanja Ćirković Veličković, Dimitrije Nikolić, Dejan Škorić, Philippe Eigenmann. Hypersensitivity reactions to antiepileptic drugs in children. Pediatric Allergy and Immunology 2019; 30(5): 547 doi: 10.1111/pai.13055
|
10 |
Andreas J. Bircher, Knut Brockow. Cutaneous Drug Hypersensitivity. 2022; : 257 doi: 10.1007/978-3-030-82743-4_29
|
11 |
Mu-Tzu Chu, Chuang-Wei Wang, Wan-Chun Chang, Chun-Bing Chen, Wen-Hung Chung, Shuen-Iu Hung. Granulysin-Based Lymphocyte Activation Test for Evaluating Drug Causality in Antiepileptics-Induced Severe Cutaneous Adverse Reactions. Journal of Investigative Dermatology 2021; 141(6): 1461 doi: 10.1016/j.jid.2020.11.027
|
12 |
Supitchaya Thaiwat, Pattareewan Rojanapanthu. Cutaneous adverse drug eruption: the role of drug patch testing. International Journal of Dermatology 2023; 62(1): 108 doi: 10.1111/ijd.16398
|
13 |
Ha Na Kim, Seo Yeon Kim, Kyung Min Kim, Yoon Hong Chun, Hyun Hee Kim, Jin Tack Kim. DRESS (drug reaction with eosinophilia and systemic symptoms) syndrome induced by lamotrigine in a child. Allergy, Asthma & Respiratory Disease 2022; 10(1): 66 doi: 10.4168/aard.2022.10.1.66
|
14 |
Semanur Kuyucu, Jean-Christoph Caubet. Hypersensitivity Reactions to Antiepileptic Drugs in Children: Epidemiologic, Pathogenetic, Clinical, and Diagnostic Aspects. The Journal of Allergy and Clinical Immunology: In Practice 2018; 6(6): 1879 doi: 10.1016/j.jaip.2018.07.003
|
15 |
Anton C. de Groot. Patch testing in drug reaction with eosinophilia and systemic symptoms (DRESS): A literature review. Contact Dermatitis 2022; 86(6): 443 doi: 10.1111/cod.14090
|
16 |
Francesca Mori, Natalia Blanca‐Lopez, Jean‐Christoph Caubet, Pascal Demoly, George Du Toit, Eva R. Gomes, Semanur Kuyucu, Antonino Romano, Ozge Soyer, Sophia Tsabouri, Marina Atanaskovic‐Markovic, Philippe Eigenmann. Delayed hypersensitivity to antiepileptic drugs in children. Pediatric Allergy and Immunology 2021; 32(3): 425 doi: 10.1111/pai.13409
|
17 |
Ana Dioun Broyles, Aleena Banerji, Sara Barmettler, Catherine M. Biggs, Kimberly Blumenthal, Patrick J. Brennan, Rebecca G. Breslow, Knut Brockow, Kathleen M. Buchheit, Katherine N. Cahill, Josefina Cernadas, Anca Mirela Chiriac, Elena Crestani, Pascal Demoly, Pascale Dewachter, Meredith Dilley, Jocelyn R. Farmer, Dinah Foer, Ari J. Fried, Sarah L. Garon, Matthew P. Giannetti, David L. Hepner, David I. Hong, Joyce T. Hsu, Parul H. Kothari, Timothy Kyin, Timothy Lax, Min Jung Lee, Kathleen Lee-Sarwar, Anne Liu, Stephanie Logsdon, Margee Louisias, Andrew MacGinnitie, Michelle Maciag, Samantha Minnicozzi, Allison E. Norton, Iris M. Otani, Miguel Park, Sarita Patil, Elizabeth J. Phillips, Matthieu Picard, Craig D. Platt, Rima Rachid, Tito Rodriguez, Antonino Romano, Cosby A. Stone, Maria Jose Torres, Miriam Verdú, Alberta L. Wang, Paige Wickner, Anna R. Wolfson, Johnson T. Wong, Christina Yee, Joseph Zhou, Mariana Castells. Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. The Journal of Allergy and Clinical Immunology: In Practice 2020; 8(9): S16 doi: 10.1016/j.jaip.2020.08.006
|